Hans Bitter

1 Patent

• US123446572025

  CD20 Therapies, CD22 Therapies, and Combination Therapies with a CD19 Chimeric Antigen Receptor (car)-expressing Cell

  The Trustees Of The University Of Pennsylvania

  0 cites